title: Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
abstract: Infection by members of the Gram-negative bacterial genus Brucella causes brucellosis in a variety of mammals. Brucellosis in swine remains a challenge, as there is no vaccine in the USA approved for use in swine against brucellosis. Here, we developed an improved recombinant Brucella abortus vaccine strain RB51 that could afford protection against Brucella suis infection by over-expressing genes encoding homologous proteins: L7/L12 ribosomal protein, Cu/Zn superoxide dismutase [SOD] and glycosyl-transferase [WboA]. Using strain RB51leuB as a platform and an antibiotic-resistance marker free plasmid, strains RB51leuB/SOD, RB51leuB/SOD/L7/L12 and RB51leuB/SOD/WboA were constructed to over-express the antigens: SOD alone, SOD and ribosomal protein L7/L12 or SOD and glycosyl-transferase, respectively. The ability of these vaccine candidates to protect against a virulent B. suis challenge were evaluated in a mouse model. All vaccine groups protected mice significantly (P<0.05) when compared to the control group. Within the vaccine groups, the mice vaccinated with strain RB51leuB/SOD/WboA were significantly better protected than those that were vaccinated with either strain RB51leuB/SOD or RB51leuB/SOD/L7/L12. These results suggest that Brucella antigens can be over-expressed in strain RB51leuB and elicit protective immune responses against brucellosis. Since the plasmid over-expressing homologous antigens does not carry an antibiotic resistance gene, it complies with federal regulations and therefore could be used to develop safer multi-species vaccines for prevention of brucellosis caused by other species of Brucella.
authors.affiliation: Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, Virginia-Maryland Regional College of Veterinary Medicine, 1410 Price's Fork Road, Blacksburg, VA 24061-0342, USA.
authors.forename: Parthiban
authors.initials: P
authors.lastname: Rajasekaran
authors.forename: Naveen
authors.initials: N
authors.lastname: Surendran
authors.forename: Mohamed N
authors.initials: MN
authors.lastname: Seleem
authors.forename: Nammalwar
authors.initials: N
authors.lastname: Sriranganathan
authors.forename: Gerhardt G
authors.initials: GG
authors.lastname: Schurig
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Boyle
mesh_terms: D000818:Animals; D000942:Antigens, Bacterial / Q000096:biosynthesis / Q000276:immunology*; D058491:Bacterial Load; D002004:Brucella Vaccine / Q000235:genetics / Q000276:immunology*; D002003:Brucella abortus / Q000235:genetics / Q000276:immunology*; D041021:Brucella suis / Q000276:immunology* / Q000472:pathogenicity*; D002006:Brucellosis / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D004195:Disease Models, Animal; D005260:Female; D015870:Gene Expression; D005964:Glucosyltransferases / Q000235:genetics / Q000276:immunology; D007930:Leucine / Q000172:deficiency*; D051379:Mice; D008807:Mice, Inbred BALB C; D012269:Ribosomal Proteins / Q000235:genetics / Q000276:immunology; D013154:Spleen / Q000382:microbiology; D013482:Superoxide Dismutase / Q000235:genetics / Q000276:immunology; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D002004:Brucella Vaccine; D012269:Ribosomal Proteins; D014613:Vaccines, Attenuated; D013482:Superoxide Dismutase; D005964:Glucosyltransferases; D007930:Leucine